Stay updated on Trastuzumab Deruxtecan Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants,' clarifying that the study is not currently enrolling. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting and the site revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer revision label was updated from v3.5.4 to v3.5.5. This indicates a new release iteration of the site, without changes to core study content shown on the page.SummaryDifference0.0%

- Check28 days agoChange DetectedTwo new update dates (2026-05-27 and 2026-05-26) were added to the study record's history. Two earlier dates (2026-05-12 and 2026-05-13) were removed, reflecting changes in the record's timeline.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's version metadata was updated to v3.5.4, along with corresponding date stamps, indicating a minor maintenance release. There are no apparent changes to the study details or displayed information.SummaryDifference0.1%

- Check49 days agoChange DetectedA new reference, Yu J, Mehta R. Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma, was added to the Publications section. The addition expands the list of cited literature associated with the study.SummaryDifference0.0%

- Check56 days agoChange DetectedIn the Locations section, Taoyuan District, Taiwan, 33305 was deleted and Taoyuan, Taiwan, 33305 was added.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Deruxtecan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.